Arcadia Biosciences (NASDAQ:RKDA) reported quarterly sales of $3.86 million which beat the analyst consensus estimate of $2.29 million by 68.47 percent. This is a 174.59 percent increase over sales of $1.41 million the same period last year.
Verano Simplifies Its Capital Structure
Verano Holdings Corp. (OTCQX: VRNOF) (CSE:VRNO) has simplified its capital structure by completing the conversion of all its outstanding class B proportionate voting shares (“PV shares”) into
